The total number of physicians prescribing cannabidiol-based products for pharmacy purchase rose from 6,300 in 2021 to 15,400 last year, an increase of 146 percent.
The Brazilian Health Surveillance Agency, Anvisa, approved a regulation on the production, import, and sale of cannabis-derived medication.
Brazil’s Health Surveillance Agency—Anvisa in the original acronym—approved two public consultations on the regulation of the controlled cultivation of Cannabis sativa in Brazil for medical and scientific purposes and the registration of medication produced with the plant’s ac
Português 
Español 
